Jeffrey D Bradley MD FASTRO

Radiation Oncology•Philadelphia, PA

Thoracic Cancer

Professor of Radiation Oncology University of Pennsylvania Perelman School of Medicine

Join to View Full Profile

3400 Civic Center Blvd, 2-WestPhiladelphia, PA 19104
Phone+1 215-349-8430

Education & Training

University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1994 - 1998
University of Chicago (NorthShore)Internship, Internal Medicine, 1993 - 1994
University of Arkansas For Medical Sciences College of MedicineClass of 1993

Certifications & Licensure

GA State Medical License 2019 - 2027
MO State Medical License 1998 - 2026
NY State Medical License 2022 - 2026
PA State Medical License 2023 - 2026
IL State Medical License 1997 - 2020
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connelly, 2020-2023
America's Top Doctors Castle Connolly, 2010-2019
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2001 Jul 01
Completed
Phase 1, Phase 2
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer Start of enrollment: 2006 Feb 01
Completed
Not Applicable
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2007 Nov 01
Completed
Phase 3
A Phase I/II Trial of Stereotactic Body Radiation Therapy Start of enrollment: 2006 Sep 21
Completed
Phase 1, Phase 2
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer Start of enrollment: 2009 Feb 01
Completed
Phase 1, Phase 2
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
COMPLETED
PHASE2, PHASE3
Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 2012 Feb 22
Active, not recruiting
Phase 2
Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain Start of enrollment: 2012 Apr 26
Completed
Phase 1, Phase 2
Proton Beam Therapy to Treat Esophageal Cancer Start of enrollment: 2014 Jan 01
Terminated
Phase 1
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer Start of enrollment: 2014 May 22
Completed
Phase 1
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer Start of enrollment: 2016 Aug 04
Active, not recruiting
Phase 1
Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy Start of enrollment: 2018 Jun 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy.
Jenna Rocchetti, Nikhil Yegya-Raman, Michelle Iocolano, William P Levin, Keith A Cengel
Radiotherapy and Oncology. 2025-07-01
Analysis of Medicare Reimbursement Trends in Medical and Radiation Oncology.
Jacob S Hogan, John C Baumann, Neha Vapiwala, Jeff M Michalski, Benjamin W Fischer-Valuck
Practical Radiation Oncology. 2025-06-09
Reply to: Mid-Treatment Positron Emission Tomography-Adaptive Radiotherapy in Stage III Non-Small Cell Lung Cancer: Another Attempt Toward Personalized Care.
Feng-Ming Spring Kong, Chen Hu, Jeffrey D Bradley, Mitchell Machtay
Journal of Clinical Oncology. 2025-06-01

Lectures

PACIFIC-2: Phase 3 study of concurrent durvalumab and platinum-based chemoradiotherapy in patients with unresectable, stage III NSCLC.
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

Extending the Reach of Proton TherapyMay 29th, 2024
Clinical Challenge: Finding the Right Regimen in EGFR-Positive NSCLCJune 18th, 2021
Jeremy Rich Named Deputy Director of Research at UPMC Hillman Cancer CenterFebruary 5th, 2021
Join now to see all

Committees

Member, Definitive and Adjuvant Radiotherapy in Locally Advanced Non-small Cell Lung Cancer Guideline Panel, American Society for Radiation Oncology 2015 - Present